by purvi | Feb 28, 2026 | featured, news and press
< Back to Sanius content Gene Therapy’s Inflexion Point: From Scientific Breakthrough to Systemic Transformation. Gene therapy has now moved decisively from scientific ambition to clinical reality, and in doing so, it has redefined what is possible for...
by purvi | Jan 13, 2026 | featured, news and press
< Back to Sanius content A Field in Motion: From Understanding to Momentum in Sickle Cell Disorder. For much of modern medicine, sickle cell disorder has been managed rather than transformed. Care pathways have focused on crisis response, symptom control, and...
by purvi | Dec 17, 2025 | featured, news and press
< Back to Sanius content RISE I A Major Collaborative Programme Advancing Safety in Advanced Cancer Therapies. As advanced cancer therapies continue to move from research into routine care, attention is increasingly turning to how these treatments are experienced...
by purvi | Dec 12, 2025 | featured, news and press
< Back to Sanius content Deepening Insight into Vaso-Occlusive Crises in Sickle Cell Disease | Evolving Patterns for AI-Driven Prediction at ASH 2025 As ASH 2025 approaches, we are pleased to share new work that digs deeper into one of the most difficult realities...
by purvi | Nov 12, 2025 | featured, news and press
< Back to Sanius content Rewriting the Pathway I The MHRA’s Rare Therapies Policy Paper, and What This Means for Patients, Evidence, and Market Access With more than 3.5 million people living with rare diseases in the UK, affecting 1 in 17 patients and carers...
by purvi | Oct 2, 2025 | featured, news and press
< Back to Sanius content AI breakthroughs predict painful crises in sickle cell disease before they strike. Millions of patients worldwide living with sickle cell disease (SCD) could soon have the power to anticipate painful vaso-occlusive crises (VOCs) before they...